This is a Validated Antibody Database (VAD) review about human S100A7A, based on 5 published articles (read how Labome selects the articles), using S100A7A antibody in all methods. It is aimed to help Labome visitors find the most suited S100A7A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
S100A7A synonym: NICE-2; NICE2; S100A15; S100A7L1; S100A7f; protein S100-A7A; S100 calcium-binding protein A15; S100 calcium-binding protein A7-like 1; koebnerisin

Santa Cruz Biotechnology
mouse monoclonal (47C1068)
  • western blot; human; 1:1000; loading ...; fig 1
Santa Cruz Biotechnology S100A7A antibody (SantaCruz, 47C1068) was used in western blot on human samples at 1:1000 (fig 1). Proteomes (2017) ncbi
mouse monoclonal (H-8)
  • western blot; human; 1:100; loading ...; fig 2d
Santa Cruz Biotechnology S100A7A antibody (Santa Cruz Biotechnology, sc-377084) was used in western blot on human samples at 1:100 (fig 2d). Breast Cancer Res (2017) ncbi
mouse monoclonal (47C1068)
  • western blot; human; loading ...; fig 3g
Santa Cruz Biotechnology S100A7A antibody (Santa, sc52948) was used in western blot on human samples (fig 3g). Cancer Res (2016) ncbi
mouse monoclonal (47C1068)
  • immunohistochemistry - paraffin section; human; 1:500; fig st1
Santa Cruz Biotechnology S100A7A antibody (Santa Cruz, sc-52948) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig st1). Oncogenesis (2015) ncbi
mouse monoclonal (47C1068)
  • immunohistochemistry - paraffin section; human; 1:500
Santa Cruz Biotechnology S100A7A antibody (Santa Cruz Biotechnology, sc-52948) was used in immunohistochemistry - paraffin section on human samples at 1:500. Int J Cancer (2014) ncbi
Articles Reviewed
  1. Pucci Minafra I, Di Cara G, Musso R, Cancemi P, Albanese N, Roz E, et al. Retrospective Proteomic Screening of 100 Breast Cancer Tissues. Proteomes. 2017;5: pubmed publisher
  2. Sakurai M, Miki Y, Takagi K, Suzuki T, Ishida T, Ohuchi N, et al. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment. Breast Cancer Res. 2017;19:70 pubmed publisher
  3. Eichten A, Su J, Adler A, Zhang L, Ioffe E, Parveen A, et al. Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade. Cancer Res. 2016;76:2327-39 pubmed publisher
  4. Chauhan S, Kaur J, Kumar M, Matta A, Srivastava G, Alyass A, et al. Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer. Oncogenesis. 2015;4:e147 pubmed publisher
  5. Kaur J, Matta A, Kak I, Srivastava G, Assi J, Leong I, et al. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer. 2014;134:1379-88 pubmed publisher